Biomagnetics Diagnostics Corp. Stock

Stocks

BMGP

US09062Q1085

Advanced Medical Equipment & Technology

OTC Markets Traded
Market Closed - 04:40:11 22/11/2022 HKT 5-day change 1st Jan Change
0.000100 USD -.--% Intraday chart for Biomagnetics Diagnostics Corp. +9,900.00% +9,900.00%
Current month+9,900.00%
1 month+9,900.00%

Valuation: Biomagnetics Diagnostics Corp.

Market Cap 3.23M 2.84M 2.68M 2.44M 4.57M 310M 4.6M 32.11M 12.44M 158M 12.12M 11.85M 513M P/E 2009
-6.29x
P/E 2010 -22.9x
Enterprise Value 3.36M 2.96M 2.79M 2.55M 4.76M 323M 4.8M 33.48M 12.97M 164M 12.63M 12.36M 535M EV / Sales 2009
-
EV / Sales 2010 -
Free-Float
100%
Yield 2009 *
-
Yield 2010 -
1 week+9,900.00%
Current month+9,900.00%
1 month+9,900.00%
3 months+9,900.00%
6 months+9,900.00%
Current year+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0.01
Manager TitleAgeSince
Chief Executive Officer - 26/02/1997
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+9,900.00%+9,900.00%+9,900.00% 277
+1.97%+3.05%+44.96%+34.93% 251B
+1.00%+5.30%+20.36%-9.90% 157B
+0.31%+4.17%-10.02%+38.63% 141B
+0.13%+2.59%-54.44%-16.64% 64.75B
-1.26%-2.86%+14.83%+23.07% 49.41B
+1.16%-0.32%-16.02%-20.32% 47.09B
+4.55%+10.55%+38.96%+55.14% 48.73B
+2.31%+0.13%+47.04%+59.96% 42.28B
+7.25%+11.71%+190.12%+106.81% 41.36B
Average +1.74%+2.84%+1,017.58%+1,017.17% 84.29B
Weighted average by Cap. +1.56%+3.46%+25.23%+25.39%

Financials

2009 2010
Net sales - -
Net income -1.17M -1.03M -972K -887K -1.66M -112M -1.67M -11.66M -4.52M -57.25M -4.4M -4.3M -186M -238K -210K -198K -180K -337K -22.88M -340K -2.37M -919K -11.64M -895K -875K -37.89M
Net Debt 126K 111K 105K 95.4K 178K 12.11M 180K 1.25M 486K 6.16M 473K 463K 20.05M 137K 121K 114K 104K 194K 13.2M 196K 1.37M 530K 6.72M 516K 505K 21.85M
Logo Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company’s diagnostics system focuses on real-time testing for the actual presence of the virus or toxin or disease itself and not for antibodies produced by the body's immune system which may take anywhere from weeks to months to appear. The Company’s products include High Throughput Screening - Magnetic Testing Platform (HTS-MTP) and Integrity Optical Biosensor (IOBS). Its HTS-MTP is designed to detect both qualitative chemical identification of the elements present in a substance and quantitative number of specific elements in a substance results from a single test. The Company triggered optical biosensor that is based on protein-receptor binding that brings two or more optically tagged receptors into close proximity using planar optical waveguides, thereby triggering fluorescence changes identified almost instantly by tiny on-board detectors.
Employees
2
  1. Stock Market
  2. Stocks
  3. BMGP Stock